Search Within

Brian Carl Shaffer

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (13)
Groups
  1. Bone Marrow Transplant (27)
  2. Center for Hematologic Malignancies (27)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Sloan Kettering Institute Postdocs (27)
  6. GSK Faculty (22)

More Groups

People
  1. Sergio Giralt (23)
  2. Miguel-Angel Perales (20)
  3. Esperanza Papadopoulos (19)
  4. Ann Jakubowski (16)
  5. Roni Tamari (15)
  6. Boglarka Gyurkocza (13)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publications
  1. Blood (9)
  2. Biology of Blood and Marrow Transplantation (5)
  3. Blood Advances (5)
  4. American Journal of Hematology (1)
  5. Bone Marrow Transplantation (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Elsevier Inc. (5)
  3. American Association for the Advancement of Science (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Science Ltd. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PHF6 mutations defines a subgroup of mixed phenotype of acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Xiao, W.; Pastore, F.; Getta, B.; Hultquist, A.; Shaffer, B. C.; Giralt, S. A.; Rampal, R. K.; Arcila, M. E.; Levine, R. L.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • KIR3DL1/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation
    Journal Article

    Boudreau, J. E.; Giglio, F.; Gooley, T. A.; Stevenson, P. A.; Le Luduec, J. B.; Shaffer, B. C.; Rajalingam, R.; Hou, L.; Hurley, C. K.; Noreen, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase II study of haploidentical natural killer cell infusion for treatment of relapsed or persistent myeloid malignancies following allogeneic hematopoietic cell transplantation
    Journal Article

    Shaffer, B. C.; Le Luduec, J. B.; Forlenza, C.; Jakubowski, A. A.; Perales, M. A.; Young, J. W.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save